Ben Amos’ Post

An innovator worth flagging up: Bioptimus ticks many boxes, including a founding team with stellar #techbio #bigtech track records. Google DeepMind Owkin #generativeAI #foundationmodel #dataanalytics #bioinformatics #computationalbiology #unravellingbiology #startup https://lnkd.in/eqieXY9j

Insightful interview with Greg Meyers, CDO at Bristol Myers Squibb, about AI in biopharma. I found his perspective on AI startups particularly interesting. Meyers draws a compelling parallel between today's AI biotech startups and the early days of internet search engines. He notes, 'If you rewind the clock to maybe 1998, there were about 12 different search engines. You didn't know whether Lycos or Yahoo or Google were going to win.'This comparison highlights the exciting potential in the current AI biotech landscape. While some may see redundancy, I see a thriving ecosystem of innovation. Each startup brings unique approaches and solutions, pushing the boundaries of what's possible in drug discovery and development.Yes, not every AI startup will become the 'Google' of biotech, but that's the nature of innovation. The diversity of approaches ensures we're exploring all possible avenues to breakthrough discoveries. As Meyers points out, the market will eventually clear out solutions looking for problems. But in this process, we're bound to uncover transformative technologies that could revolutionize healthcare.For biotech entrepreneurs and investors, this is an exhilarating time. The competition is driving rapid advancements, and I believe we'll see some truly groundbreaking innovations emerge from this space. #AIinPharma #BiopharmaInnovation #FutureOfDrugDiscovery"

🎉 I'm beyond excited to join Xatoms as AI Lead! 🎉 Working alongside the visionary team Diana Virgovicova, Kerem Topalismailoglu and Shirley Zhong is truly a dream come true. Their groundbreaking work in AI and quantum chemistry for water purification is nothing short of revolutionary! 🚀💧 Xatoms' recent achievements are mind-blowing: - $500,000 investment secured 💰 - Named BEST STARTUP at Startupfest 🏆 - Top 6 out of 10,000 startups at Hult Prize Foundation - Backed by Amazon Web Services (AWS), Creative Destruction Lab and more! But what truly inspires me is Xatoms' mission: Using AI and quantum chemistry to discover new photocatalytic materials that can clean polluted water and change lives globally. Did you know women and girls spend 200 MILLION HOURS daily searching for water? Xatoms is working to dramatically reduce this number! I can't wait to contribute my AI expertise to accelerate our impact! Let's make clean water accessible to EVERYONE! 💙 #CleanWaterForAll #AIForGood #QuantumChemistry #XAtoms

🌟 Exciting News in the World of Drug Discovery! 🌟 Chai Discovery secures a significant $30 million investment from Thrive Capital and OpenAI to revolutionize drug discovery processes. Thrive led the seed round, joined by Dimension Capital, valuing Chai at an impressive $150 million. Co-founder Joshua Meier, with a rich background from Absci Corp., Meta Platforms, and OpenAI, heads a talented team comprising individuals from leading tech firms. In a groundbreaking move, Chai unveils its first open-source model, Chai-1, boasting a 10% to 20% higher success rate in drug discovery tasks compared to competitors like AlphaFold and ESM3. The industry is abuzz with excitement over AI's potential to streamline drug discovery, with significant milestones achieved by tech giants like Google DeepMind's AlphaFold and EvolutionaryScale's AI model for protein generation. Watch more about Chai Discovery's game-changing innovations https://lnkd.in/eMnV4DKK #DrugDiscovery #AI #Innovation #TechNews

Pointward & the DE² @xespinc can make the claim of reaching 4 PEOPLE PER SECOND with the products and procedures it has commercialized from the likes of big companies like Boston Science, Johnson & Johnson, Medtronic etc., midsize companies and startups. We do this globally, around the clock 365 days a year.  Today there are 2 types of companies, those using AI to Digitally transform their Ecosystem as well as, leveraging machine learning / AI to grow their business. The 2nd are those companies not using these tools at all or not using them efficiently & effectively and won't be in business soon. -Mark Cuban #healthcare #medicine #medicaldevices #medtech

𝗧𝗵𝗲 𝗙𝗮𝘀𝘁𝗲𝘀𝘁 𝗚𝗿𝗼𝘄𝗶𝗻𝗴 𝗗𝗲𝗲𝗽 𝗧𝗲𝗰𝗵 𝗔𝗿𝗲𝗮𝘀 𝗮𝗻𝗱 𝗔𝘀𝗰𝗲𝗻𝗱𝗶𝗻𝗴 𝗣𝗮𝘁𝗲𝗻𝘁 𝗖𝗮𝘁𝗲𝗴𝗼𝗿𝗶𝗲𝘀 As we confront novel and complex problems, the need for radical solutions becomes ever more pressing. And the answer? 'Deep Tech' Some of the Deep Tech areas that have emerged immensely in the past few years are: → Computational biology and chemistry → Novel Energy → Space Tech → Future of Compute → Novel AI Europe's highly innovative companies working in these areas can play a decisive role in innovating the market and tackling today’s biggest challenges. According to Dealroom, investors have already invested over $13B this year. VC investment in European emerging Deep Tech startups hit record $4.3B in 2022 followed by $4.2B in 2023. The fervour for Deep Tech isn't confined to founders and investors alone; the patent landscape reflects widespread public approval. Among all sectors, machine learning stands out with the highest number of patents, nearing 800 since 2016. Other areas that are worth notable are: → Generative AI → Quantum Computing → Robotics → Semi-conductors Matter of fact, 15 of the top 30 science hubs globally are in Europe. Looking deeper, we expect these sectors to innovate greatly in the coming years, making Deep Tech a ‘problem solver’. Interested in reading the full report? Check the link and share your thoughts in the comments!   https://bit.ly/3H4j9M0   Credit: Dealroom.co Lakestar Walden Catalyst Ventures   #Venturecapital #AI #Deeptech #Startups   Follow us for strategies and resources for deep tech founders and VCs!   And get access to exclusive content on deep tech startups like planqc, kiutra, Celeris Therapeutics, and Quibim in our newsletter:   🗻 https://lnkd.in/dtTX49AF

In Q3-2024, companies who are driving innovations and pushing the thresholds of frontier technologies raised over a combined $8.1bn in funding. Key themes among others include: 1️⃣ AI is king with significant funding into AI companies across multiple sectors. We know OpenAI raised $6.6bn this week - however during the last quarter, companies like Safe Superintelligence Inc. raised ~$1bn and Cohere raised $500m. AI funding will continue to grow. 2️⃣ There were some notable Series A: Baichuan Intelligence, Skild AI, Superluminal Medicines Inc. raised $390m, $300m and $120m 3️⃣ Autonomous tech, Biotech and medicine, and energy solutions and decarbonisation also saw major fund raises. Other companies featured include: Helsing, Saronic Technologies, Astranis Space Technologies, Altana, HistoSonics, Inc., Moonshot AI, Riverlane, VSPARTICLE, Story, Cribl, Swiss-Mile, Magic, Codeium, Circle Pharma, Inc., Arsenal Biosciences, Inc., eGenesis, Inc., 24M Technologies, Candid Therapeutics, Glean, Forterra, Inflammatix, Inc., Strider Technologies, BLACKCLOAK, Serán BioScience, AIR COMPANY, Isomorphic Labs, Picus Security, Twelve, Harmonic, Torq, Utility Global, Mendaera, Inc. -- We track a wide range of innovators and key metrics, offering deeper insights into the latest trends. Follow us for regular updates and stay connected! 🔗 https://lnkd.in/epAHf4bW (article on our website) #frontiersoftechnology #AI #Innovation #funding #money

💡 𝘊𝘰𝘮𝘱𝘢𝘯𝘺 S𝘱𝘰𝘵𝘭𝘪𝘨𝘩𝘵 💡- Weave ❓ 𝑫𝒊𝒅 𝒚𝒐𝒖 𝒌𝒏𝒐𝒘 that their #mission is to provide AI-enabled solutions that support accelerated time to market so treatments can get to patients faster. 🎉 They have just announced $10 million in seed funding led by Innovation Endeavors and Magnetic Ventures! Funding will be used to accelerate efforts to streamline the 'therapeutic lifecycle'. 🤖 Weave also launched their flagship '𝑨𝒖𝒕𝒐𝑰𝑵𝑫' platform which automates and accelerates the preparation, writing, and review process for INDs. The IND submission process, crucial for moving potential therapies from labs to clinical trials, has traditionally been a time-consuming and manual endeavor. 🧑🔬Based, New Haven and Co-Founded by Ari Caroline & Umut Eser, Weave also announced the appointment of Lindsay Mateo, MBA as CCO which highlights the trajectory they are on! 🌏 Want to learn more, click on the webpage - https://www.weave.bio/. They are one to be following for the rest of the year in the build up to Series A funding... #seedfunding #AI

Incredible news from Israel! Despite the challenges we face, innovation continues to thrive. Meta has selected 10 groundbreaking Israeli AI startups for their Tel Aviv accelerator program, providing them with resources and mentorship to advance their technology. Israel's dedication to pushing boundaries in AI and tech is a testament to our resilience and creativity. We are not just overcoming obstacles—we're changing the world! #IsraelInnovation #AI #Resilience #TechTransformation https://lnkd.in/edsp2-my

🤔 A Venture Capital director/doctor (Namrata Rastogi, MD), a founder/doctor (Dr. Keith Tsui), a venture partner (Gemma Bloemen), and a serial entrepreneur (Janardan Prasad) walk into Google HQ to talk about AI in healthcare … What results in an incredibly balanced and insightful discussion on the current state of AI in healthcare and what the future might hold. Here were my key takeaways: 1️⃣ Data Privacy & Security: Emerging AI models can now be trained offline, reducing data leak risks. 2️⃣ The present: Lots of AI innovation is currently happening in administration, radiology, and primary care. 3️⃣ The future: As we move into the AI-enabled healthcare generation, these are some developments that were exciting to the panel: - Multimodal LLMs: Personalized health AI by integrating e-records, genetics, drug data, and more. - Preventative Health: Early risk detection by connecting data points before disease onset. - Evolving Data Privacy: Future preference for AI-only data access to minimize redundant questioning. - Explainability: AI-driven transparency in clinical decisions. 4️⃣ Challenges & Considerations: - The quality and accuracy of data input into LLMs are crucial—reducing "hallucinations" and improving output quality are key areas of focus. - Healthcare tech needs to be tailored not just for the industry but for specific local healthcare needs. Great to meet so many people Jesko Bartelt Isabel Van De Keere, PhD Filip Wolski Christina Bell